ABA Chemicals Corporation
雅本化学
300261
Shenzhen Stock Exchange
Company Profile
ABA is actively promoting its future-oriented "2+X" strategy, with innovative pharmaceutical and agricultural CDMO (Contract Development and Manufacturing Organization) businesses as the core. It firmly implements the "Key Customer Strategy," establishing sustained and stable strategic cooperative relationships with leading global pharmaceutical and agrochemical enterprises. The company has made in-depth deployments in innovative pharmaceutical and pesticide intermediates as well as derivative products, forming a gradient product matrix, and is steadily advancing the industrialization process. Meanwhile, the forward-looking layout and capability building in synthetic biology, flow chemistry, and green carbon reduction inject sustained momentum into the long-term development of its core businesses. Through the full-chain closed-loop synergy of the three core systems—"R&D Innovation, Intelligent Manufacturing, and Green Carbon Reduction"—the company has built core competitiveness that emphasizes both short-term growth and long-term resilience. Furthermore, ABA takes intelligentization as a key driver for future development and adheres to the tenet of "supplementing, extending, and strengthening the industrial chain" to build a full-life-cycle "R&D-Production" industrial chain that meets the needs of high-end and innovative products.
Full description
During the reporting period, driven by the global pesticide industry’s inventory destocking and the phase-out of outdated production capacity, the pesticide industry gradually recovered, with signs of a rebound in demand becoming evident. In the first half of 2025, the company’s pesticide intermediate business showed a recovery trend, and the order volume in the second quarter achieved steady growth compared with the first quarter. During the reporting period, the company achieved a total operating revenue of RMB 661.6711 million, representing a year-on-year increase of 12.31%; the net profit attributable to shareholders of listed companies was RMB -8.6684 million, with a year-on-year reduction in losses of 83.33%. In the second quarter of 2025, the operating revenue increased by 9.61% quarter-on-quarter compared with the first quarter, and the company turned losses into profits in a single quarter.